Products Categories
CAS No.: | 116002-70-1 |
---|---|
Name: | ONDANSETRON |
Article Data: | 30 |
Molecular Structure: | |
Formula: | C18H19N3O |
Molecular Weight: | 293.368 |
Synonyms: | 9-METHYL-3-[(2-METHYLIMIDAZOL-1-YL)METHYL]-2,3-DIHYDRO-1H-CARBAZOL-4-ONE; |
EINECS: | 1308068-626-2 |
PSA: | 39.82000 |
LogP: | 3.12850 |
Molecular Structure of 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- (CAS NO.99614-02-5):
Molecular Formula: C18H19N3O
Molecular Weight: 293.363
IUPAC Name: 9-Methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one
Synonyms of 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- (CAS NO.99614-02-5): Ondansetron [USAN:INN:BAN] ; (RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one ; 1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one ; BRN 3622981 ; GR 38032 ; GR 38032X ; Odansetron [common misspelling of ondansetron] ; UNII-4AF302ESOS ; Zofran ; Zofran ODT ; Zophren ; Zudan
CAS NO: 99614-02-5
Classification Code: Anti-anxiety agents ; Antiemetics ; Antipruritics ; Antipsychotic agents ; Autonomic Agents ; Central Nervous System Agents ; Central Nervous System Depressants ; Dermatologic Agents ; Drug / Therapeutic Agent ; Gastrointestinal Agents ; Human Data ; Neurotransmitter Agents ; Peripheral Nervous System Agents ; Psychotropic Drugs ; Serotonin Agents ; Serotonin antagonists ; Tranquilizing Agents
Index of Refraction: 1.677
Molar Refractivity: 86.75 cm3
Molar Volume: 230.1 cm3
Surface Tension: 48.9 dyne/cm
Density: 1.27 g/cm3
Flash Point: 284 °C
Enthalpy of Vaporization: 82.5 kJ/mol
Boiling Point: 546 °C at 760 mmHg
Vapour Pressure of 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)- (CAS NO.99614-02-5): 5.62E-12 mmHg at 25°C
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD | intravenous | > 10mg/kg (10mg/kg) | Seminars in Oncology. Vol. 19(Suppl, | |
man | TDLo | intravenous | 229ug/kg/I (0.229mg/kg) | LIVER: "JAUNDICE, OTHER OR UNCLASSIFIED" | Lancet. Vol. 344, Pg. 190, 1994. |
mouse | LD | intraperitoneal | > 5mg/kg (5mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 46, Pg. 401, 1996. | |
mouse | LD | oral | > 10mg/kg (10mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 46, Pg. 401, 1996. | |
mouse | LDLo | intravenous | 2500ug/kg (2.5mg/kg) | Seminars in Oncology. Vol. 19(Suppl, | |
rat | LDLo | intravenous | 20mg/kg (20mg/kg) | Seminars in Oncology. Vol. 19(Suppl, |